Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 19221167

The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Oncologist
Publication date
2009 Mar
First author
Scagliotti G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Scagliotti G
      type
      Author
    2. name
      Hanna N
      type
      Author
    3. name
      Fossella F
      type
      Author
    4. name
      Sugarman K
      type
      Author
    5. name
      Blatter J
      type
      Author
    6. name
      Peterson P
      type
      Author
    7. name
      Simms L
      type
      Author
    8. name
      Shepherd FA
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Scagliotti G
      type
      Author
    2. name
      Hanna N
      type
      Author
    3. name
      Fossella F
      type
      Author
    4. name
      Sugarman K
      type
      Author
    5. name
      Blatter J
      type
      Author
    6. name
      Peterson P
      type
      Author
    7. name
      Simms L
      type
      Author
    8. name
      Shepherd FA
      type
      Author
    bibliography ids
    1. nci-bib-a446225a0879411e18a5d7a5
    book metadata
    content sha256
    55b9bfceddb6b93f749a0df82e55cfce55aa7c116d8b2ec39a97a09e9afc9a2c
    document type
    citation
    dois
    1. 10.1634/theoncologist.2008-0232
    electronic publication date
    display
    2009 Feb 16
    precision
    day
    year
    2009
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:19221167
    immutable id
    pubmed:19221167@55b9bfceddb6b93f749a0df82e55cfce55aa7c116d8b2ec39a97a09e9afc9a2c
    journal
    abbreviation
    Oncologist
    issn electronic
    1549-490X
    issn print
    1083-7159
    issue
    3
    name
    The oncologist
    nlm unique id
    9607837
    pages
    253-63
    volume
    14
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      19221167
      provenance
      batch id
      27a383f06e5fc3d04fad
      provider
      NCBI PubMed ESummary
      record sha256
      afe619db3fcd4ed65f945bd3b784b33119e96bc9cc132718ffaded1f1ba8dbba
      response sha256
      51f0f2a142dbd9b135e872b049b116f51941299445a5416feae10f12fac8d978
      retrieved at
      2026-09-09T23:46:24.265787+00:00
      publication date
      display
      2009 Mar
      precision
      month
      year
      2009
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/19221167/
      title
      The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies.

      Preserved source evidence · Not medical advice